The Norwegian Nucleoside Analogue Stop Study

NCT03681132 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

127

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

OTHER: Stop of therapy

Sponsor

Oslo University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]